Higher values of TFQI are associated with obesity, metabolic syndrome, impaired renal function, diabetes, and diabetes-related mortality. In a large population of community-dwelling euthyroid subjects the<unk>  predicted all-cause mortality, even after adjustment for other established risk factors and comorbidities. Serum Concentrations of Adipocyte Fatty Acid-Binding Protein (A-FABP) are significantly correlateted to TFQI, suggesting some form of cross-talk between adipose tissue and HPT axis. TFQI results are also elevated in takotsubo syndrome, potentially reflecting type 2 allostatic load in the situation of psychosocial stress. Reductions have been observed in subjects with schizophrenia after initiation of therapy with oxcarbazepine and quetiapine, potentially reflecting declining allostatic load. Despite positive association to metabolic syndrome and type 2 allostatic load a large population-based study failed to identify an association to risks of dyslipidemia and non-alcoholic fatty liver disease (NAFLD).
Thyroid Feedback Quantile-based Index
Jostel's TSH index
Combined rapid anterior pituitary evaluation panel
The Quality of Life Assessment of Growth Hormone Deficiency in Adults Measure
Thyroid hormone binding ratio
Free androgen index
Molecular and Cellular Endocrinology
Testosterone-cortisol ratio